7C01

Molecular basis for a potent human neutralizing antibody targeting SARS-CoV-2 RBD


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.88 Å
  • R-Value Free: 0.265 
  • R-Value Work: 0.218 
  • R-Value Observed: 0.220 

wwPDB Validation   3D Report Full Report


This is version 1.3 of the entry. See complete history


Literature

A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2.

Shi, R.Shan, C.Duan, X.Chen, Z.Liu, P.Song, J.Song, T.Bi, X.Han, C.Wu, L.Gao, G.Hu, X.Zhang, Y.Tong, Z.Huang, W.Liu, W.J.Wu, G.Zhang, B.Wang, L.Qi, J.Feng, H.Wang, F.S.Wang, Q.Gao, G.F.Yuan, Z.Yan, J.

(2020) Nature 584: 120-124

  • DOI: 10.1038/s41586-020-2381-y
  • Primary Citation of Related Structures:  
    7C01

  • PubMed Abstract: 
  • An outbreak of the coronavirus disease 2019 (COVID-19) 1-3 , caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 4 spread globally. Countermeasures are needed to treat and prevent further dissemination of ...

    An outbreak of the coronavirus disease 2019 (COVID-19) 1-3 , caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 4 spread globally. Countermeasures are needed to treat and prevent further dissemination of the virus. In this study, we report the isolation of 2 specific human monoclonal antibodies (MAbs) from a convalescent COVID-19 patient. CA1 and CB6 demonstrated potent SARS-CoV-2-specific neutralization activity in vitro against SARS-CoV-2. In addition, CB6 inhibited SARS-CoV-2 infection in rhesus monkeys at both prophylactic and treatment settings. Further structural studies revealed that CB6 recognizes an epitope that overlaps with angiotensin converting enzyme 2 (ACE2)-binding sites in SARS-CoV-2 receptor binding domain (RBD), thereby interfering with the virus/receptor interactions by both steric hindrance and direct interface-residue competition. Our results suggest CB6 deserves further clinical translation.


    Organizational Affiliation

    Savaid Medical School, University of Chinese Academy of Sciences, Beijing, 100049, China. yanjh@im.ac.cn.



Macromolecules
Find similar proteins by:  (by identity cutoff)  |  Structure
Entity ID: 1
MoleculeChainsSequence LengthOrganismDetailsImage
SARS-Cov-2 Spike protein S1AB229Severe acute respiratory syndrome coronavirus 2Mutation(s): 0 
Gene Names: S2
Find proteins for P0DTC2 (Severe acute respiratory syndrome coronavirus 2)
Explore P0DTC2 
Go to UniProtKB:  P0DTC2
Protein Feature View
Expand
  • Reference Sequence
Find similar proteins by:  (by identity cutoff)  |  Structure
Entity ID: 2
MoleculeChainsSequence LengthOrganismDetailsImage
CB6 heavy chainCH233Homo sapiensMutation(s): 0 
Protein Feature View
Expand
  • Reference Sequence
Find similar proteins by:  (by identity cutoff)  |  Structure
Entity ID: 3
MoleculeChainsSequence LengthOrganismDetailsImage
CB6 light chainDL217Homo sapiensMutation(s): 0 
Protein Feature View
Expand
  • Reference Sequence
Small Molecules
Ligands 1 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
NAG
Query on NAG

Download CCD File 
A, B
2-acetamido-2-deoxy-beta-D-glucopyranose
C8 H15 N O6
OVRNDRQMDRJTHS-FMDGEEDCSA-N
 Ligand Interaction
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.88 Å
  • R-Value Free: 0.265 
  • R-Value Work: 0.218 
  • R-Value Observed: 0.220 
  • Space Group: P 21 21 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 87.4α = 90
b = 106.73β = 90
c = 170.59γ = 90
Software Package:
Software NamePurpose
PHENIXrefinement
Blu-Icedata collection
HKL-2000data reduction
UCSD-systemdata processing
PHASERphasing
HKL-2000data scaling

Structure Validation

View Full Validation Report



Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Chinese Academy of SciencesChinaXDB29040201
Ministry of Science and Technology (MoST, China)China2018ZX09711003
Ministry of Science and Technology (MoST, China)China2020YFC0841400
National Natural Science Foundation of China (NSFC)China81922044

Revision History 

  • Version 1.0: 2020-05-27
    Type: Initial release
  • Version 1.1: 2020-06-10
    Changes: Database references
  • Version 1.2: 2020-07-29
    Type: Remediation
    Reason: Carbohydrate remediation
    Changes: Data collection, Derived calculations, Structure summary
  • Version 1.3: 2020-08-19
    Changes: Database references, Structure summary